These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 24824375)

  • 1. NOS3 tagSNPs does not modify the chronic kidney disease progression in autosomal dominant polycystic kidney disease.
    Ramanathan G; Periyasamy S; Lakkakula BV
    Nephrology (Carlton); 2014 Sep; 19(9):537-41. PubMed ID: 24824375
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of angiotensin converting enzyme (
    Ramanathan G; Ghosh S; Elumalai R; Periyasamy S; Lakkakula BV
    Indian J Med Res; 2016 Jun; 143(6):748-755. PubMed ID: 27748299
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aldosterone synthase gene is not a major susceptibility gene for progression of chronic kidney disease in patients with autosomal dominant polycystic kidney disease.
    Ramanathan G; Elumalai R; Periyasamy S; Lakkakula BVKS
    Saudi J Kidney Dis Transpl; 2017; 28(3):552-557. PubMed ID: 28540892
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angiotensinogen gene polymorphisms and progression of chronic kidney disease in ADPKD patients.
    Gnanasambandan R; Elumalai R; Soundararajan P; Lakkakula BVKS
    Clin Exp Nephrol; 2016 Aug; 20(4):561-568. PubMed ID: 26482465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modifier effect of the Glu298Asp polymorphism of endothelial nitric oxide synthase gene in autosomal-dominant polycystic kidney disease.
    Stefanakis N; Ziroyiannis P; Trygonis S; Lamnissou K
    Nephron Clin Pract; 2008; 110(2):c101-6. PubMed ID: 18815450
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renin gene rs1464816 polymorphism contributes to chronic kidney disease progression in ADPKD.
    Ramanathan G; Elumalai R; Periyasamy S; Lakkakula BV
    J Biomed Sci; 2016 Jan; 23():1. PubMed ID: 26753721
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence for association of endothelial cell nitric oxide synthase gene polymorphism with earlier progression to end-stage renal disease in a cohort of Hellens from Greece and Cyprus.
    Lamnissou K; Zirogiannis P; Trygonis S; Demetriou K; Pierides A; Koptides M; Deltas CC
    Genet Test; 2004; 8(3):319-24. PubMed ID: 15727257
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of endothelial nitric oxide synthase VNTR (intron 4 a/b) polymorphism on the progression of renal disease in autosomal dominant polycystic kidney disease.
    Elumalai R; Periasamy S; Ramanathan G; Lakkakula BV
    J Renal Inj Prev; 2014; 3(3):69-73. PubMed ID: 25340172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endothelin 1 gene is not a major modifier of chronic kidney disease advancement among the autosomal dominant polycystic kidney disease patients.
    Annapareddy SN; Elumalai R; Lakkakula BV; Ramanathan G; Periyasamy S
    J Nephropharmacol; 2016; 5(1):13-18. PubMed ID: 28197493
    [No Abstract]   [Full Text] [Related]  

  • 10. Association of NOS3 gene polymorphisms with essential hypertension in Sudanese patients: a case control study.
    Gamil S; Erdmann J; Abdalrahman IB; Mohamed AO
    BMC Med Genet; 2017 Nov; 18(1):128. PubMed ID: 29132319
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of endothelial nitric oxide synthase gene on end stage renal disease progression in autosomal dominant polycystic kidney disease.
    Xue C; Zhou CC; Sun LJ; He LL; Xu CG; Dai B; Mei CL
    Nephrology (Carlton); 2014 Oct; 19(10):630-7. PubMed ID: 24995932
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of VEGF polymorphism on progression of autosomal dominant polycystic kidney disease.
    Reiterová J; Obeidová H; Lenícek M; Stekrová J; Merta M; Maixnerová D; Vítek L; Viklický O; Tesar V
    Kidney Blood Press Res; 2008; 31(6):398-403. PubMed ID: 19060482
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of endothelin-1 gene polymorphisms on the progression of autosomal dominant polycystic kidney disease.
    Reiterová J; Merta M; Stekrová J; Cabartová Z; Cibulka R; Maixnerová D; Rysavá R; Ríhová Z; Tesar V; Motán J
    Kidney Blood Press Res; 2006; 29(3):182-8. PubMed ID: 16943682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NOS3 gene intron 4 a/b polymorphism is associated with ESRD in autosomal dominant polycystic kidney disease patients.
    Padhi UN; Mulkalwar M; Saikrishna L; Verma HK; Bhaskar L
    J Bras Nefrol; 2022; 44(2):224-231. PubMed ID: 35138322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The influence of G-protein beta3-subunit gene and endothelial nitric oxide synthase gene in exon 7 polymorphisms on progression of autosomal dominant polycystic kidney disease.
    Reiterová J; Miroslav M; Stekrová J; Kohoutová M; Tesar V; Kmentová D; Hubácek JA; Viklický O
    Ren Fail; 2004 Mar; 26(2):119-25. PubMed ID: 15287194
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polymorphisms of the NOS3 gene in Tunisian patients with Behçet's disease.
    Kallel A; Sbaï MH; Houman MH; Sediri Y; Ouertani D; Smiti Khanfir M; Ben Ghorbel I; Jemaa R; Kaabachi N
    Int J Immunogenet; 2015 Apr; 42(2):87-92. PubMed ID: 25639851
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Variants within the nitric oxide synthase 1 gene are associated with stroke susceptibility.
    Manso H; Krug T; Sobral J; Albergaria I; Gaspar G; Ferro JM; Oliveira SA; Vicente AM
    Atherosclerosis; 2012 Feb; 220(2):443-8. PubMed ID: 22153699
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NOS3 as a potential modifier of ADPKD phenotypic variability: progress towards an answer.
    Mallett A; Sandford R
    Nephrology (Carlton); 2014 Dec; 19(12):733-4. PubMed ID: 25403989
    [No Abstract]   [Full Text] [Related]  

  • 19. Endothelial nitric oxide synthase affects the progression of autosomal dominant polycystic kidney disease.
    Reiterová J; Merta M; Tesar V; Stekrová J
    Kidney Blood Press Res; 2002; 25(2):87-90. PubMed ID: 12077489
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Variable renal disease progression in autosomal dominant polycystic kidney disease: a role for nitric oxide?
    Devuyst O
    J Nephrol; 2003; 16(3):449-52. PubMed ID: 12832751
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.